Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored mailed nicotine replacement therapy and relapse prevention for smokers awaiting elective surgery
ACTRN12619000032156Phase 4Completed
- Sponsor
- Dr Ashley Webb
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicotine in nicotine dependence (2 arms), sponsored by Dr Ashley Webb. Primary endpoint: Smoking cessation for more than 24 hours by day of surgery. Started Apr 2019; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12619000032156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000032156.